Cagrilintide With Semaglutide: A Way to Prevent Diabesity?
CagriSema (cagrilintide plus semaglutide) led to weight loss 'of a magnitude not previously reported with pharmacotherapies in type 2 diabetes,' plus improved CGM measures, in a phase 2 trial.
Medscape Medical News
source https://www.medscape.com/viewarticle/993665?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/993665?src=rss
Comments
Post a Comment